Drug Approval | August 31, 2023
Ajanta Pharma receives USFDA for Topiramate Extended Release Capsules
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
Farxiga is expected to have such a strong influence on the market due to the impressive results
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
